• Je něco špatně v tomto záznamu ?

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

H. Yanai, A. Kagramanova, O. Knyazev, J. Sabino, S. Haenen, GJ. Mantzaris, K. Mountaki, A. Armuzzi, D. Pugliese, F. Furfaro, G. Fiorino, D. Drobne, T. Kurent, S. Yassin, N. Maharshak, F. Castiglione, R. de Sire, OM. Nardone, K. Farkas, T. Molnar,...

. 2022 ; 16 (12) : 1882-1892. [pub] 2022Dec05

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu multicentrická studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032250

BACKGROUND: Endoscopic-post-operative-recurrence [ePOR] in Crohn's disease [CD] after ileocecal resection [ICR] is a major concern. We aimed to evaluate the effectiveness of early prophylaxis with biologics and to compare anti-tumour necrosis factor [anti-TNF] therapy to vedolizumab [VDZ] and ustekinumab [UST] in a real-world setting. METHODS: A retrospective multicentre study of CD-adults after curative ICR on early prophylaxis was undertaken. ePOR was defined as a Rutgeerts score [RS] ≥ i2 or colonic-segmental-SES-CD ≥ 6. Multivariable logistic regression was used to evaluate risk factors, and inverse probability treatment weighting [IPTW] was applied to compare the effectiveness between agents. RESULTS: The study included 297 patients (53.9% males, age at diagnosis 24 years [19-32], age at ICR 34 years [26-43], 18.5% smokers, 27.6% biologic-naïve, 65.7% anti-TNF experienced, 28.6% two or more biologics and 17.2% previous surgery). Overall, 224, 39 and 34 patients received anti-TNF, VDZ or UST, respectively. Patients treated with VDZ and UST were more biologic experienced with higher rates of previous surgery. ePOR rates within 1 year were 41.8%. ePOR rates by treatment groups were: anti-TNF 40.2%, VDZ 33% and UST 61.8%. Risk factors for ePOR at 1 year were: past-infliximab (adjusted odds ratio [adj.OR] = 1.73 [95% confidence interval, CI: 1.01-2.97]), past-adalimumab [adj.OR = 2.32 [95% CI: 1.35-4.01] and surgical aspects. After IPTW, the risk of ePOR within 1 year of VDZ vs anti-TNF or UST vs anti-TNF was comparable (OR = 0.55 [95% CI: 0.25-1.19], OR = 1.86 [95% CI: 0.79-4.38]), respectively. CONCLUSION: Prevention of ePOR within 1 year after surgery was successful in ~60% of patients. Patients treated with VDZ or UST consisted of a more refractory group. After controlling for confounders, no differences in ePOR risk were seen between anti-TNF prophylaxis and other groups.

CEMAD IBD UNIT Unità Operativa Complessa di Medicina Interna e Gastroenterologia Dipartimento di Scienze Mediche e Chirurgiche Fondazione Policlinico Universitario 'A Gemelli' IRCCS Rome Italy

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Madrid Spain

Clinical and Research Centre for Inflammatory Bowel Disease ISCARE Clinical Centre Prague Czech Republic

Concord Medical Center Clalit Health Services Bnei Brak Israel

Department of Clinical Medicine and Surgery University of Naples Federico 2 Naples Italy

Department of Gastroenterology and Hepatology Kaplan Medical Center Rehovot Israel

Department of Gastroenterology and Hepatology University Hospital of Santiago de Compostela Santiago de Compostela Spain

Department of Gastroenterology and Liver Diseases Tel Aviv Medical Center Tel Aviv Israel

Department of Gastroenterology Austin Hospital Melbourne VIC Australia

Department of Gastroenterology Faculty of Medicine and Health Örebro University Örebro Sweden

Department of Gastroenterology GHA 'Evaggelismos Ophthalmiatreion Athinon Polykliniki' Athens Greece

Department of Gastroenterology Hepatology and Nutrition University Hospital Centre Zagreb Croatia

Department of Gastroenterology Hospital Universitario de La Princesa Instituto de Investigación Sanitaria Princesa Spain

Department of Gastroenterology Lyon Sud hospital Hospices Civils de Lyon Lyon and INSERM U1111 CIRI Lyon France

Department of Gastroenterology Metaxa Memorial General Hospital Piraeus Greece

Department of Gastroenterology Rambam Health Care Campus Haifa Israel

Department of Gastroenterology Sheba Medical Center Tel Hashomer Israel

Department of Gastroenterology St Vincent's Hospital Melbourne VIC Australia

Department of Gastroenterology The Northern Care Alliance NHS Foundation Trust Manchester Academic Health Sciences University of Manchester Manchester UK

Department of Gastroenterology University Hospitals of Leuven Leuven Belgium

Department of Gastroenterology University Medical Centre Ljubljana Ljubljana Slovenia

Department of Gastroenterology Venizeleio General Hospital Heraklion Crete Greece

Department of Gastroenterology with IBD Unit Clinical Hospital No 2 Rzeszów Poland

Department of Internal Medicine and Pediatrics Ghent University Ghent Belgium

Department of Internal Medicine Medical Faculty University of Ljubljana Ljubljana Slovenia

Department of Medical Sciences University of Turin Turin Italy

Department of Medicine University of Melbourne Melbourne VIC Australia

Department of Medicine University of Szeged Szeged Hungary

Department of Public Health University of Naples Federico 2 Naples Italy

Department of Surgical Oncological and Gastroenterological Sciences Gastroenterology Unit Padua University Padua Italy

Digestive Diseases Institute Shaare Zedek Medical Center Jerusalem Israel

Division of Gastroenterology and Center for Autoimmune Liver Diseases Department of Medicine and Surgery University of Milano Bicocca Monza Italy

Division of Gastroenterology Hospital Beatriz Ângelo Loures Lisbon Portugal

Division of Gastroenterology Hospital da Luz Lisboa Portugal

Division of Gastroenterology Mater Dei Hospital Msida Malta

Division of Gastroenterology Rabin Medical Center Petah Tikva Israel

European Reference Network on Hepatological Diseases San Gerardo Hospital Monza Italy

Faculty of Medicine Hebrew University Jerusalem Israel

Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel

Gastroenterology and Endoscopy IRCCS Ospedale San Raffaele and Vita Salute San Raffaele University Milan Italy

Gastroenterology Department Hospital de Bellvitge and IDIBELL L'Hospitalet Spain

Gastroenterology Department University Hospital of Heraklion Crete Greece

Gastroenterology Unit Department of Systems Medicine University of Rome Tor Vergata Italy

Gastroenterology Unit Rho Hospital ASST Rhodense Rho Italy

IBD Center Humanitas Research Hospital IRCCS Milan Italy

IBD Center IRCCS Humanitas Research Hospital Rozzano Milan Italy

IBD unit Department of Gastroenterology University Hospital Ghent Ghent Belgium

Imelda GI clinical Research Center Department of Gastroenterology Imelda General Hospital Bonheiden Belgium

Inflammatory Bowel Disease Center Department of Gastroenterology Radboud University Medical Center Nijmegen The Netherlands and Division of Gastroenterology Department of Medicine University of Alberta Edmonton Canada

Institute of Gastroenterology Meir Hospital Sapir Medical Center Kfar Saba Israel

Institute of Medical Biochemistry and Laboratory Medicine General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Irkutsk Scientific Center of Surgery and Traumatology Russia

Moscow Clinical Scientific Centre named after A S Loginov Moscow Russian Federation

Rappaport Faculty of Medicine The Technion Israel Institute of Technology Haifa Israel

Research Institute of Health Organization and Medical Management Moscow Russian Federation

Sackler Faculty of Medicine Tel Aviv University Israel

State Scientific Centre of Coloproctology named after A N Ryzhyh Moscow Russian Federation

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032250
003      
CZ-PrNML
005      
20230131151539.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ecco-jcc/jjac100 $2 doi
035    __
$a (PubMed)35895074
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Yanai, Henit $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
245    10
$a Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study / $c H. Yanai, A. Kagramanova, O. Knyazev, J. Sabino, S. Haenen, GJ. Mantzaris, K. Mountaki, A. Armuzzi, D. Pugliese, F. Furfaro, G. Fiorino, D. Drobne, T. Kurent, S. Yassin, N. Maharshak, F. Castiglione, R. de Sire, OM. Nardone, K. Farkas, T. Molnar, Z. Krznaric, M. Brinar, E. Chashkova, M. Livne Margolin, U. Kopylov, C. Bezzio, A. Bar-Gil Shitrit, M. Lukas, M. Chaparro, M. Truyens, S. Nancey, T. Lobaton, JP. Gisbert, S. Saibeni, P. Bacsúr, P. Bossuyt, J. Schulberg, F. Hoentjen, C. Viganò, A. Palermo, J. Torres, J. Revés, K. Karmiris, M. Velegraki, E. Savarino, P. Markopoulos, E. Tsironi, P. Ellul, C. Calviño Suárez, R. Weisshof, D. Ben-Hur, T. Naftali, C. Eriksson, IE. Koutroubakis, K. Foteinogiannopoulou, JK. Limdi, E. Liu, G. Surís, E. Calabrese, F. Zorzi, R. Filip, DG. Ribaldone, Y. Snir, I. Goren, H. Banai-Eran, Y. Broytman, H. Amir Barak, I. Avni-Biron, JE. Ollech, I. Dotan, M. Aharoni Golan
520    9_
$a BACKGROUND: Endoscopic-post-operative-recurrence [ePOR] in Crohn's disease [CD] after ileocecal resection [ICR] is a major concern. We aimed to evaluate the effectiveness of early prophylaxis with biologics and to compare anti-tumour necrosis factor [anti-TNF] therapy to vedolizumab [VDZ] and ustekinumab [UST] in a real-world setting. METHODS: A retrospective multicentre study of CD-adults after curative ICR on early prophylaxis was undertaken. ePOR was defined as a Rutgeerts score [RS] ≥ i2 or colonic-segmental-SES-CD ≥ 6. Multivariable logistic regression was used to evaluate risk factors, and inverse probability treatment weighting [IPTW] was applied to compare the effectiveness between agents. RESULTS: The study included 297 patients (53.9% males, age at diagnosis 24 years [19-32], age at ICR 34 years [26-43], 18.5% smokers, 27.6% biologic-naïve, 65.7% anti-TNF experienced, 28.6% two or more biologics and 17.2% previous surgery). Overall, 224, 39 and 34 patients received anti-TNF, VDZ or UST, respectively. Patients treated with VDZ and UST were more biologic experienced with higher rates of previous surgery. ePOR rates within 1 year were 41.8%. ePOR rates by treatment groups were: anti-TNF 40.2%, VDZ 33% and UST 61.8%. Risk factors for ePOR at 1 year were: past-infliximab (adjusted odds ratio [adj.OR] = 1.73 [95% confidence interval, CI: 1.01-2.97]), past-adalimumab [adj.OR = 2.32 [95% CI: 1.35-4.01] and surgical aspects. After IPTW, the risk of ePOR within 1 year of VDZ vs anti-TNF or UST vs anti-TNF was comparable (OR = 0.55 [95% CI: 0.25-1.19], OR = 1.86 [95% CI: 0.79-4.38]), respectively. CONCLUSION: Prevention of ePOR within 1 year after surgery was successful in ~60% of patients. Patients treated with VDZ or UST consisted of a more refractory group. After controlling for confounders, no differences in ePOR risk were seen between anti-TNF prophylaxis and other groups.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a biologické přípravky $x terapeutické užití $7 D001688
650    12
$a Crohnova nemoc $x farmakoterapie $x prevence a kontrola $x chirurgie $7 D003424
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
650    _2
$a inhibitory TNF $x terapeutické užití $7 D000079424
650    _2
$a ustekinumab $x terapeutické užití $7 D000069549
650    _2
$a mladý dospělý $7 D055815
655    _2
$a multicentrická studie $7 D016448
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kagramanova, Anna $u Moscow Clinical Scientific Centre named after. A.S. Loginov, Moscow, Russian Federation
700    1_
$a Knyazev, Oleg $u Moscow Clinical Scientific Centre named after. A.S. Loginov, Moscow, Russian Federation $u State Scientific Centre of Coloproctology named after A.N. Ryzhyh, Moscow, Russian Federation $u Research Institute of Health Organization and Medical Management, Moscow, Russian Federation
700    1_
$a Sabino, João $u Department of Gastroenterology, University Hospitals of Leuven, Leuven, Belgium
700    1_
$a Haenen, Shana $u Department of Gastroenterology, University Hospitals of Leuven, Leuven, Belgium
700    1_
$a Mantzaris, Gerassimos J $u Department of Gastroenterology, GHA 'Evaggelismos-Ophthalmiatreion Athinon-Polykliniki', Athens, Greece
700    1_
$a Mountaki, Katerina $u Department of Gastroenterology, GHA 'Evaggelismos-Ophthalmiatreion Athinon-Polykliniki', Athens, Greece
700    1_
$a Armuzzi, Alessandro $u IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
700    1_
$a Pugliese, Daniela $u CEMAD, IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy
700    1_
$a Furfaro, Federica $u IBD Center, Humanitas Research Hospital-IRCCS, Milan, Italy
700    1_
$a Fiorino, Gionata $u Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy $1 https://orcid.org/0000000156232968
700    1_
$a Drobne, David $u Department of Internal Medicine, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia $u Department of Gastroenterology, University Medical Centre Ljubljana, Ljubljana, Slovenia $1 https://orcid.org/000000032734675X
700    1_
$a Kurent, Tina $u Department of Gastroenterology, University Medical Centre Ljubljana, Ljubljana, Slovenia
700    1_
$a Yassin, Sharif $u Sackler Faculty of Medicine, Tel Aviv University, Israel $u Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
700    1_
$a Maharshak, Nitsan $u Sackler Faculty of Medicine, Tel Aviv University, Israel $u Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
700    1_
$a Castiglione, Fabiana $u Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
700    1_
$a de Sire, Roberto $u Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy $1 https://orcid.org/0000000264482649
700    1_
$a Nardone, Olga Maria $u Department of Public Health, University of Naples Federico II, Naples, Italy
700    1_
$a Farkas, Klaudia $u Department of Medicine, University of Szeged, Szeged, Hungary
700    1_
$a Molnar, Tamas $u Department of Medicine, University of Szeged, Szeged, Hungary $1 https://orcid.org/0000000238429094
700    1_
$a Krznaric, Zeljko $u Department of Gastroenterology, Hepatology and Nutrition, University Hospital Centre, Zagreb, Croatia
700    1_
$a Brinar, Marko $u Department of Gastroenterology, Hepatology and Nutrition, University Hospital Centre, Zagreb, Croatia
700    1_
$a Chashkova, Elena $u Irkutsk Scientific Center of Surgery and Traumatology, Russia
700    1_
$a Livne Margolin, Moran $u Sackler Faculty of Medicine, Tel Aviv University, Israel $u Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel
700    1_
$a Kopylov, Uri $u Sackler Faculty of Medicine, Tel Aviv University, Israel $u Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Israel
700    1_
$a Bezzio, Cristina $u Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho (MI), Italy
700    1_
$a Bar-Gil Shitrit, Ariella $u Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel $u Faculty of Medicine, Hebrew University, Jerusalem, Israel
700    1_
$a Lukas, Milan $u Clinical and Research Centre for Inflammatory Bowel Disease, ISCARE Clinical Centre, Prague, Czech Republic $u Institute of Medical Biochemistry and Laboratory Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Chaparro, María $u Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS- Princesa), Universidad Autónoma de Madrid (UAM), Spain $u Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain $1 https://orcid.org/0000000292754242
700    1_
$a Truyens, Marie $u IBD unit, Department of Gastroenterology, University Hospital Ghent, Ghent, Belgium $u Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
700    1_
$a Nancey, Stéphane $u Department of Gastroenterology, Lyon-Sud hospital, Hospices Civils de Lyon, Lyon and INSERM U1111, CIRI, Lyon, France
700    1_
$a Lobaton, Triana $u IBD unit, Department of Gastroenterology, University Hospital Ghent, Ghent, Belgium $u Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
700    1_
$a Gisbert, Javier P $u Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS- Princesa), Universidad Autónoma de Madrid (UAM), Spain $u Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
700    1_
$a Saibeni, Simone $u Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho (MI), Italy $1 https://orcid.org/0000000156772534
700    1_
$a Bacsúr, Péter $u Department of Medicine, University of Szeged, Szeged, Hungary
700    1_
$a Bossuyt, Peter $u Imelda GI clinical Research Center, Department of Gastroenterology, Imelda General Hospital, Bonheiden, Belgium $1 https://orcid.org/0000000340277365
700    1_
$a Schulberg, Julien $u Department of Gastroenterology, St Vincent's Hospital, Melbourne, VIC, Australia $u Department of Medicine, University of Melbourne, Melbourne, VIC, Australia $u Department of Gastroenterology, Austin Hospital, Melbourne, VIC, Australia
700    1_
$a Hoentjen, Frank $u Inflammatory Bowel Disease Center, Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands and Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada
700    1_
$a Viganò, Chiara $u Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy $u European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy
700    1_
$a Palermo, Andrea $u Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy $u European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy
700    1_
$a Torres, Joana $u Division of Gastroenterology, Hospital da Luz Lisboa, Portugal $u Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Lisbon, Portugal $1 https://orcid.org/0000000328955821
700    1_
$a Revés, Joana $u Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Lisbon, Portugal
700    1_
$a Karmiris, Konstantinos $u Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece
700    1_
$a Velegraki, Magdalini $u Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece $1 https://orcid.org/0000000341280718
700    1_
$a Savarino, Edoardo $u Department of Surgical Oncological & Gastroenterological Sciences (DiSCOG), Gastroenterology Unit, Padua University, Padua, Italy
700    1_
$a Markopoulos, Panagiotis $u Department of Gastroenterology, Metaxa Memorial General Hospital, Piraeus, Greece
700    1_
$a Tsironi, Eftychia $u Department of Gastroenterology, Metaxa Memorial General Hospital, Piraeus, Greece
700    1_
$a Ellul, Pierre $u Division of Gastroenterology Mater Dei Hospital, Msida, Malta
700    1_
$a Calviño Suárez, Cristina $u Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
700    1_
$a Weisshof, Roni $u Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel $u Rappaport Faculty of Medicine, The Technion - Israel Institute of Technology, Haifa, Israel
700    1_
$a Ben-Hur, Dana $u Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel $u Rappaport Faculty of Medicine, The Technion - Israel Institute of Technology, Haifa, Israel
700    1_
$a Naftali, Timna $u Institute of Gastroenterology, Meir Hospital Sapir Medical Center, Kfar Saba, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Eriksson, Carl $u Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden $1 https://orcid.org/000000021046383X
700    1_
$a Koutroubakis, Ioannis E $u Gastroenterology Department, University Hospital of Heraklion, Crete, Greece
700    1_
$a Foteinogiannopoulou, Kalliopi $u Gastroenterology Department, University Hospital of Heraklion, Crete, Greece $1 https://orcid.org/0000000305545256
700    1_
$a Limdi, Jimmy K $u Department of Gastroenterology, The Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences, University of Manchester, Manchester, UK
700    1_
$a Liu, Eleanor $u Department of Gastroenterology, The Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences, University of Manchester, Manchester, UK
700    1_
$a Surís, Gerard $u Gastroenterology Department, Hospital de Bellvitge and IDIBELL, L'Hospitalet, Spain
700    1_
$a Calabrese, Emma $u Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy
700    1_
$a Zorzi, Francesca $u Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy
700    1_
$a Filip, Rafał $u Department of Gastroenterology with IBD Unit, Clinical Hospital No. 2, Rzeszów, Poland
700    1_
$a Ribaldone, Davide Giuseppe $u Department of Medical Sciences, University of Turin, Turin, Italy $1 https://orcid.org/0000000294213087
700    1_
$a Snir, Yifat $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Goren, Idan $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel $1 https://orcid.org/0000000221622840
700    1_
$a Banai-Eran, Hagar $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Broytman, Yelena $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Amir Barak, Hadar $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Avni-Biron, Irit $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel $1 https://orcid.org/0000000191426530
700    1_
$a Ollech, Jacob E $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Dotan, Iris $u Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel $u Sackler Faculty of Medicine, Tel Aviv University, Israel
700    1_
$a Aharoni Golan, Maya $u Department of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel $u Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel $u Concord Medical Center, Clalit Health Services, Bnei Brak, Israel
773    0_
$w MED00166945 $t Journal of Crohn's & colitis $x 1876-4479 $g Roč. 16, č. 12 (2022), s. 1882-1892
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35895074 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151534 $b ABA008
999    __
$a ok $b bmc $g 1891167 $s 1183585
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 16 $c 12 $d 1882-1892 $e 2022Dec05 $i 1876-4479 $m Journal of Crohn's and colitis $n J Crohns Colitis $x MED00166945
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...